From Discovery to Preclinical Proof-of-Concept — in vitro & in vivo Solutions, Powered by Advanced Models & Integrated CRO Expertise
Cyagen leverages AI-assisted workflows and rapid model generation to optimize study design and accelerate early development. Integrated in vitro and in vivo platforms enable efficient progression to proof-of-concept.
Access HUGO-GT™ human ortholog and HUGO-Ab™ models and 18,000+ validated rodent models to improve translational relevance. Applications span oncology, CNS, and rare diseases, with robust PK/PD, biodistribution, and efficacy studies.
We develop custom gene-edited and iPSC-based models for mechanistic studies, screening, and validation. These systems align seamlessly with in vivo studies to strengthen translational outcomes.
Featured Experts
Resources
Swags & Offers
Featured Experts
As the Chief Scientific Officer at Cyagen, Dr. Ouyang oversees the company’s scientific operations and strategic development of genetically engineered mouse model services. With over two decades of experience in the field, Dr. Ouyang has led innovations that have advanced Cyagen’s global leadership in custom model generation. He is passionate about bridging cutting-edge technologies with translational research to accelerate biomedical discoveries. Before joining Cyagen in 2012, Dr. Ouyang served as the head of Molecular Biology at Taconic Biosciences.
Delaine is a scientist-turned business development leader with a strong background in metabolism, circadian biology, and cancer research. She completed a B.A. in Biology at the University of Puerto Rico before earning her Ph.D. in Biochemistry from the University of Pennsylvania. She then transitioned from academic research into a commercial role, supporting therapeutic innovation.
Her expertise spans diverse modalities—antibodies, small molecules, ADCs, CAR-T, mRNA, siRNA, peptides, oligonucleotides, AAV, and gene editing—across oncology, immunology, cardiovascular, neuroscience, and ophthalmology.
She now leverages her scientific training and strategic approach to connect researchers—from academic groups to global pharmaceutical teams—with solutions that accelerate discovery and advance innovation.
Spotlight Presentation
Swags & Offers
